ESOPMay 18, 2026, 04:03 PM
C4 Therapeutics Grants 85,480 Stock Options to New Employee
AI Summary
C4 Therapeutics announced that its Board's Organization, Leadership and Compensation Committee approved an inducement grant of non-qualified stock options for 85,480 shares to a new employee on May 18, 2026. This grant serves as a material inducement for the individual's employment, in accordance with Nasdaq Listing Rule 5635(c)(4). The options have an exercise price equal to the closing stock price on the grant date and will vest over four years, with 25% vesting after the first year and the remainder monthly thereafter, contingent on continued employment.
Key Highlights
- C4 Therapeutics granted 85,480 non-qualified stock options to one new employee.
- The grant was made on May 18, 2026, as an inducement for employment.
- Options have an exercise price equal to the closing stock price on the grant date.
- The inducement grant vests over a four-year period.
- 25% of shares vest on the first-year anniversary of the employee's start date.
- Remaining shares vest in 36 equal monthly installments thereafter.
Price Impact
More from CCCC